Sarissa Capital Management LP
Q1 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
7
- Value ($000)
$154,710
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001577524
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
INVA INNOVIVA INC | COM | 45781M101 | $51.05M | 33 % | 2,816,022 | ||
NBIX NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $34.19M | 22 % | 309,116 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $24.11M | 16 % | 600,000 | ||
IRWD IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | $24.09M | 16 % | 16,390,000 | ||
EH3A AMARIN CORP PLC | SPONS ADR NEW | 023111206 | $11.14M | 7 % | 24,850,623 | ||
LNTH LANTHEUS HLDGS INC | COM | 516544103 | $9.76M | 6 % | 100,000 | ||
VOR VOR BIOPHARMA INC | COM | 929033108 | $364.50K | 0 % | 508,016 |
Rows Per Page
10
- 10
- 50
- 100